| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Starlab We believe in progress through science. Our solutions enable bright minds to change the world. We believe in progress through science. Our solutions enable bright minds to change the world. We are “Passionate for Science”. Since 1998. Our product portfolio specializes in the field of Liquid Handling Technology and laboratory products. Our product portfolio includes laboratory consumables such as pipette tips, single and multi-channel pipettes, cell culture, tubes, PCR consumables, nitrile and latex gloves, and benchtop equipment for general laboratory use. Our products and services are in daily use at research institutions in biological and medical institutes, universities and hospitals, … Type: | 3 | 300 |
 | Quantgene We bring life-saving genomics to hospitals, physicians and patients everywhere. Quantgene decentralizes genomics to bring precision medicine to everyone. Our turnkey genomics platform empowers hospitals to move life-saving genomic diagnostics inside their organizations, unlock powerful new sources of revenue and become a driving force in clinical discovery. From complete genomic profiling to hereditary cancer testing and multi-cancer early detection, we help hospitals, physicians and patients to unlock the full power of precision genomics. Cancer diagnostics, biotechnology, genomics, machine learning, oncology, precision medicine, cancer screening, deep sequencing, cancer, innovation, AI, and Cancer Detection Type: | 4 | 35 |
 | EuroGalenus Executive Search Consultants Executive Search & Talent Assessment in: Industry, Service companies, Life Sciences, Digital Health, and other sectors. EuroGalenus is an International independent executive search and leadership consulting firm founded in 1992 and member of the ECI Group. Our searches are focused on the board and senior executive level of the organizations and we have a track record in fields such as Industry, Services companies, Health and Biosciences, Consultancy and Professional Services, etc. Most of our work is pan-european and we have an outstanding track record in international searches. Since 1994 EuroGalenus is also a member of the Association of Executive Search … | 4 | 4 |
 | Institut NeuroMyogène The Institut NeuroMyoGène (INMG) is a novel institute dedicated to the study of the nervous and muscular systems. It was created in 2016 in Lyon at the heart of a dense hospital network and of one of the biggest medical universities in France. The INMG goal is to unravel fundamental aspects of the cell biology of the muscle and nervous system from development to aging under normal and pathological conditions. Using a variety of invertebrate and vertebrate model systems, the INMG is conducting an integrated multidisciplinary research from gene to physiological functions. One of its priorities is to develop relevant … Type: | 4 | 105 |
 | Tebubio Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster: - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. - We accelerate their Research thanks to our Contract Research Services’ … Type: | 15 | 78 |
 |  CeleScreen CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity by means of Caenorhabditis elegans, a <1mm nematode, long-known model for human metabolism. It is a unique solution for systemic toxicity, reprotoxicity, teratogenicity, while avoiding vertebrate testing. Primary targets are in the cosmetics industry to face REACH demands. Celescreen has recently launched collaborative projects incorporating C. elegans and in silico approaches for drug development in human health. Incorporated in 2015, based at Hôpital Lariboisière in Paris, CeleScreen is a licensee of Assistance Publique - Hôpitaux de Paris (AP-HP), a major player in human health with >20,000 medical doctors. … Type: | 12 | 2 |
 |  BRIC-BoRdeaux Institute of onCology Cliniciens et chercheurs réunis à Bordeaux pour la recherche contre le cancer. Unité de recherche sous les tutelles Inserm et Université de Bordeaux, composée de 11 équipes de recherche sur la thématique cancer : Team A. Bikfalvi / L. Brisson / T. Mathivet Tumor and vascular biology laboratory. Team M. Khatib / F. Delom Reprogramming tumor activity and associated microenvironment (RYTME). Team V. Moreau / F. Saltel Liver cancers and tumor invasion (LCTI). Team C. Varon Helicobacter- associated digestive cancers, cancers stem cells and therapeutic strategies. Team H. Rezvani / M. Beylot Barry Translational Research in Oncodermatology and orphan skin … Type: | 26 | 78 |
 | Laboratoires URGO A French company in Family Capital, URGO laboratories are responsible for identifying the care and health needs of consumers and patients and providing innovative responses from their technological and scientific know-how. Urgo laboratories are among the laboratories recognized both by the general public and by health professionals (doctors, pharmacists, nurses, etc.). Leader in France on many markets, the company has a clear desire to develop internationally which already represents 48% of its turnover. An ambition supported by a permanent approach of innovation, significant investments in research and development, production and clinical research to demonstrate the therapeutic efficiency of products. Type: | 3 | 490 |
 | C3M - Centre Méditerranéen de Médecine Moléculaire Centre de Recherche Médicale Inserm U1065 The Mediterranean Centre for Molecular Medicine (C3M) currently includes 13 joint INSERM/university teams, representing 160 people, that focus on three major research topics: Proliferation, Cellular Death, Differentiation and Cancer Biology of Host-microorganism interactions Metabolic diseases The diversity of research interests at C3M create an enriching work environment, facilitating interdisciplinary collaborations which benefit from complementary approaches and the expertise knowledge of each team. One of the current goals of the C3M is to expand via the integration of new research teams of the highest scientific quality, and whose research complements that of the existing teams. Type: | 6 | 60 |
 | IBDM Understanding development to understand pathologies The International Marseille Development Biology Institute (IBDM) brings together under a mixed supervision of the National Center for Scientific Research (CNRS) and Aix Marseille University (AMU) 21 International Research Teams that explore the field of development biology and pathologies associated with it. The research carried out at IBDM is intended to understand the mechanisms of training, organization and function of biological systems, as well as the nature of the disturbances at the origin of many pathologies such as congenital malformations, neuro-degenerative diseases and cancers. IBDM teams implement inter-disciplinary approaches in the fields of development, physiology, … Type: | 4 | 76 |
 | Institute of NeuroPhysiopathology (INP) The Institute of NeuroPhysiopathology (UMR7051) is a CNRS / AMU training and research center studying brain disorders The Institute of NeuroPhysiopathology (INP – UMR7051) was created on January 1st 2018 and is directed by François Devred. It is located in the Timone site of the Medical Faculty of Marseille and is supported by Aix-Marseille University (AMU) and the CNRS. The INP brings together 11 teams totalling 150 people, half of whom have permanent positions (statutory staff). The main objectives of the Institute are to study on a fundamental level, through animal and cell models (including reprogramming / iPS cell modelling), … Type: | 7 | 149 |
 | CRBS - Centre de recherche en biomédecine de Strasbourg CRBS - Strasbourg Biomedicine Research Center - @INSERMEST @Unistra | account piloted by @Léabussek The Strasbourg Biomedicine Research Center (CRBS), located on the Strasbourg Hospital campus, brings together ten scientific laboratories (University of Strasbourg and Inserm). With a multithematic vocation, he developed several research axes: • Neuroscience • Inflammation-immunity • Biomaterials • Medical genetics • Cancerology It also hosts the Alsace Medical Genetics Institute of Strasbourg University Hospitals (HUS). The CRBS works in connection with the Faculty of Medicine and welcomes 300 people. The objectives of the Center: Create a center of attractiveness on the Medicine-Hospital Campus by federating research … Type: | 1 | 62 |
 | DeuterOncology NV Developing deuterated BEST in CLASS MET kinase Inhibitor DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2. Drug Development, Deuterated small molecules, and MET kinase inhibitor Type: | 0 | 3 |
 | Rewind Therapeutics Rewind Therapeutics is developing first-in-class remyelinating therapies for myelin-related diseases and aims to bring them into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition and movement, among others. The causes of damage may be genetic, a result of infectious or autoimmune disease or from exposure to toxic agents or other forms of brain injury. There is no cure for demyelinating diseases. The Company was founded by KU Leuven’s Centre for Drug Design and Discovery (CD3) and … Type: | 0 | 19 |
 | NeoPhore Ltd Discovering drugs that create neoantigens NeoPhore, UK is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system. Generation of cancer neoantigens in tumours can be exploited by the patients’ immune system to overcome natural defence mechanisms in cancer. The Company’s approach targets the DNA mismatch repair (MMR) pathway, which has been proven to promote neoantigen creation and subsequent immunity against numerous cancers. Using these insights, NeoPhore aims to generate next-generation immuno-oncology therapeutics to improve clinical outcomes for cancer patients. NeoPhore was spun-out of the University of Turin and PhoreMost … Type: | 1 | 18 |
 | Refined Laser Systems GmbH Label-free and chemically specific imaging for life science and medical diagnostics Refined is a young biophotonics company from Münster, Germany, aiming to transform the treatment of cancer. During today's cancer treatments, surgeries must be repeated in up to one third of all cases because it remains a challenge to quickly identify cancer cells without extensive biopsy processing. With its pioneering laser technology, combined with advanced microscopy methods and artificial intelligence, Refined has stepped up to empower surgeons and pathologists to overcome this challenge. fiber laser, picosecond laser, 2-photon microscopy, and microscopy Type: | 2 | 17 |
 | Humane Genomics Platform to engineer cancer killing viruses using synthetic biology. Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency. Our first indication is liver cancer. We are based in New York City and backed by amazing investors. (YC S21) Type: | 5 | 5 |
 | Actipulse Neuroscience® Neuromodulation therapeutics from the hospital, directly to the home of the patient. A Paris Brain Institute company. Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Neuromodulation, Depression, Alzheimer's, and Neurotech Type: | 6 | 38 |
 | Monument Therapeutics Bringing Precision Medicine to Neuroscience Drug Development Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021. Monument Tx develops products to treat serious diseases of the central nervous system. Our precision medicine approach utilises proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, which are then matched with appropriately targeted compounds. Using biomarkers to more accurately identify patients with a disease sub-type most likely to respond to a particular treatment is already successfully used in the treatment of cancer. Now Monument Tx brings digital biomarkers to neuroscience … Type: | 0 | 7 |
 | CELLUGY® Pushing the sustainable status quo with the force of nature We’re a Denmark-based company who’ve developed the groundbreaking platform technology EcoFLEXY that’s ready to revolutionise industries across the world with the force of nature. It allows companies to say goodbye to microplastics by replacing petrochemicals in their products without losing production momentum or performance. biodegradable material, sustainable material, plastic replacement, environmental packaging, green technology, biotechnology, personal care, textiles, cellulose, personal care products, and cosmetics Type: | 7 | 22 |
 | YD Pharmaceuticals Patient focus YD Pharmaceuticals is a pharmaceutical company, with an EU-GMP certified indoor facility producing medical cannabis and distributing to EU Countries and other markets. With a 5,000m2 state of the art indoor facility located near Porto, YD Pharmaceuticals is strategically positioned to meet patient needs across all markets. Quality, stability, transparency and patient focus are YD Pharmaceuticals core values. | 0 | 1 |
 | Tandem Therapeutics Unlocking the matrix barrier to treat fibrotic diseases TANDEM Therapeutics is a discovery stage Swiss biopharmaceutical company bringing a novel precision targeting approaches to fibrosis and fibrotic cancers. We advance over 15 years of transformative research and development at ETH Zürich and Paul Scherrer Institut in the field of extracellular matrix biology and the critical role it plays in the pathology of fibrotic cancers & organ fibrosis. The therapeutic platform is based on Matrix Targeting Peptides (MTP) that conditionally target disease associated matrix alterations that are known to be directly associated with several fibrotic diseases. Type: | 0 | 5 |
 |  Allegria Therapeutics Mastering Mast Cells Allegria Therapeutics was founded in Basel, Switzerland by Forty51 Ventures in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that directly and selectively modulate mast cells, Allegria aims to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases. For more information, please visit www.allegriatx.com Mast Cell-Targeted Therapeutics, Allergy, and Inflammatory Disease Type: | 0 | 1 |
 | Metsystem Personalized cancer patient treatment that targets metastasis. Personalized cancer patient treatment that targets metastasis. We can treat preventatively and create better patient outcome. Metsystem is developing a metastasis-targeting drug screen platform that is capable of predicting the most effective drug for each patient. With an accurate drug screen we can guide treatment and create better patient outcomes. Type: | 3 | 17 |
 | Cellsway Cellsway is a fresh deep-tech start-up founded in March 2020 in UK to convert the know-how and cutting-edge core technology that have been developed and cultivated at Mikro Biyosistemler Inc. into commercial products to set the gold standard for diagnosis and management of cancer. The flagship product of the company is a liquid biopsy platform which uses a simple blood sample for cancer diagnostics and cancer research. The patent-pending microfluidic technology enables isolation and enumeration of Circulating Tumor Cells (CTCs) from the blood samples of cancer patients. Type: | 4 | 6 |
 | TrackPaw Scientific AB We digitalise preclinical studies to increase welfare and research quality. TrackPaw Scientific's deep tech solution for 24/7 monitoring of early stage pharmaceutical development offers improved animal welfare together with better study outcomes. Biotechnology , Drug development, Machine learning, Artificial Intelligence, Deep tech, Preclinical research, Animal welfare, and 3R Type: | 1 | 10 |
 | Synerkine Pharma Creating Innovative Pain Solutions Synerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines. These fusion proteins have unique benefits over the individual cytokines and modulate a broad number of targets, including key elements in the pain pathway. This provides treatment options for chronic pain conditions with a clearly differentiated mechanism of action over current analgesic drugs and holds tremendous therapeutic and commercial potential. Synerkine Pharma B.V. was founded in 2018 as a spin-off of the University Medical Center Utrecht (UMCU), the Netherlands. Type: | 3 | 8 |
 | Egetis Therapeutics AB Pharmaceutical drug development company, focusing on late-stage development for treatment of serious rare diseases. Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment Type: | 0 | 46 |
 | Bentley Development & manufacture of innovative endovascular products for the treatment of peripheral vascular & aortic disease. Bentley’s passion is the development, manufacturing and marketing of innovative implants for minimal-invasive treatments of vascular diseases. Bentley was founded in 2009 by medical entrepreneurs Lars Sunnanväder and Miko Obradovic. The company has seen substantial growth since the launch of its first product in 2012. Since then Bentley rapidly expanded worldwide. Thanks to its international network of exclusive distribution partners Bentley is represented in more than 80 countries – in some even as market leader. Bentley is the only company worldwide that offers a … Type: | 2 | 261 |
 | Cirdan Ltd Leading provider of informatics software and imaging solutions that enhance and speed up the diagnosis of patients. Cirdan designs, manufactures and supplies innovative software and imaging solutions for the acceleration and enhancement of diagnosis. Our systems are optimised for pathology and clinical laboratory usage. Cirdan’s primary product is its world-class Laboratory Information System, ULTRA. ULTRA has been designed to streamline laboratory operations and is currently installed in more than 72 laboratories across 6 continents. Another core product is PathLite Compact, a purpose-built system designed specifically for gross imaging within clinical laboratories. The company was founded in 2010 and is headquartered … Type: | 4 | 115 |
 | ARTICA Therapeutics Development of covalent small molecules to transform the treatment of autoimmune and inflammatory disorders ARTICA Therapeutics and its seasoned team started operatons in 2020 and was supported by pre-Seed financing from BioGeneration Ventures. Artica is dedicated to developing novel small molecule medicines for inflammatory and autoimmune indicatons. Artca is at the forefront of covalent binding technology as well as in label-free cellular-based screening approaches. The unique combinaton of these capabilities allows rapid progression of the best drug candidates that have unprecedented and superior characteristics, creating novel and highly selective therapies for patients with unmet medical need. Type: | 1 | 17 |
 | RoukenBio We provide drug developers with high-quality data to give them the confidence to take their drug discovery forward. RoukenBio – CRO redefined. RoukenBio takes its tagline seriously - disrupting the traditional CRO model with a collaborative, personalised approach to drug discovery. With customers in over 27 countries, RoukenBio aims to become the most trusted research partner to biotherapeutic innovators globally. Backed by brilliant minds, RoukenBio offers a range of in vitro drug discovery services with specialist expertise across human immunology, bioanalytical, cell line engineering, molecular biology, bioassay development and safety and efficacy assessments. RoukenBio partners with therapeutic developers from early … Type: | 0 | 84 |
 | Onena Medicines AI-centric preclinical company discovering and developing novel biopharmaceuticals to treat cancer and rare diseases Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class antibody medicines to treat recurrent and metastatic cancers and selected rare diseases. Onena’s drugs neutralize a new class of secreted ancient growth factors, conserved across species, called Dual SMAD Inhibiting Proteins (DSIPs), that program cancer cells to grow and resist chemotherapy. Blocking DSIPs, as demonstrated in-vivo by Onena, simultaneously reactivates physiological TGF-β and BMP signaling and elicits cellular reprogramming, resulting in cancer cells accepting environmental cell death signals from BMPs and Activins. Onena has developed … Type: | 0 | 13 |
 | ADOR Diagnostics Molecular Diagnostics Innovations ADOR Diagnostics is an innovative IVD company that specializes in the development of cutting-edge syndromic multiplex molecular biology diagnostics technology. ADOR sets a new standard by revolutionizing the way laboratories worldwide diagnose infectious diseases with multiplex,sample-to-answer, fully automated systems that deliver accurate results rapidly. By using ADOR’s systems, laboratories can reduce costs and increase efficiency while doctors are able to treat patients with confidence, knowing they would prescribe the correct antibiotics and the right treatment. The NATlab system is a multiplex isothermal (RCA) based cutting-edge molecular biology platform with a bench-top modular analyzer and a disposable all-included … Type: | 0 | 13 |
 | ResoTher Pharma Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry Type: | 0 | 17 |
 | Pixelgen Technologies Protein interactomics by Proximity Networks® of single cells Pixelgen Technologies AB is on a mission to deliver biology at the highest resolution by understanding the molecular basis of cellular function with new tools and technologies that decipher the protein interactomics of single cells in unprecedented ways. The company’s patented Proximity Network Assay delivers nanoscale spatial analysis of immune cell proteins at ultra-high capacity and underpins the Pixelgen Proxiome Kit for precision medicine. A foundational technology, the Proximity Network Assay will power a portfolio of products for translational research to accelerate advances in immunology, hematology, and cell therapy. Pixelgen was founded … Type: | 1 | 32 |
 | LimmaTech Biologics AG Better technology for better health LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK. vaccines, research & development, biotechnology, and antimicrobial resistance Type: | 1 | 48 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 15 |
 | Double Bond Pharmaceutical International AB Double Bond Pharmaceutical is a fast growing pharmaceutical company that develops and commercializes innovative first-in-class approaches for treatment of cancers, infections, autoimmune diseases and other life-threatening disorders. The main aim of the company is to provide patients and the market with more efficient and safe products especially in areas where these needs are unmet. The human population is growing and also the life-span is increasing. Many children born today can be expected to live until they are about 100 years old. By these reasons it can be expected that the need for efficient therapies for treatment of different diseases will … Type: | 0 | 13 |
 | Blue Scientific Ltd. Distributor of market-leading scientific instruments for microscopy & materials science in the UK & Nordic region. Blue Scientific provides market-leading scientific instruments for materials science research and microscopy in the UK and Nordic region. UK and Irish distributor for: - Bruker - Micro-CT (X-ray microscopy), TXRF trace element analysis and micro-XRF elemental analysis. - CAMECA - Elemental and isotopic analysis. - Thermo Scientific - ChemiSEM SEM/EDS Nordic region (Norway, Denmark, Sweden, Finland, Iceland): - Bruker Nano Surface Analysis - AFM, 3D optical microscopes, stylus profilers, tribology and mechanical testing - Bruker - Micro-XRF elemental analysis, TXRF, Micro-CT and X-Ray analysis … Type: | 2 | 25 |
 | Predictiv Care 🧬 DNA-based Digital Twin to help predict and prevent diseases and adverse reaction to drugs Personal genomics solution for predictive medicine—Thanks to unique and groundbreaking technology, Predictiv identifies the genetic predispositions of an individual on 22,000+ diseases and simulated reactions to 750+ drugs. Now enabling more accurate preventive actions and treatments. genomics, predictive medicine, preventive medicine, heathcare, and biotechnology Type: | 18 | 9 |
 | Age Labs AS Extending human healthspan Aging is the main cause behind most illnesses that eventually kill us. Your chance of dying doubles every 8 years. By the time you turn 80, half of your peers are dead. However, it turns out aging is a biological process, amenable to treatment. Research has demonstrated that we can postpone the onset of age-related disease. Lab mice know this already. Experiments with caloric restriction, senolytics and metabolic inhibitors have extended life and reversed aging - in mice. But how do we know these treatments will work in humans? We can wait and see if patients receiving … Type: | 0 | 4 |
 | 1928 Diagnostics Where complex data turns into actionable results. 1928 Diagnostics offers a bioinformatics analytics platform for infection control. Using sequence data, 1928 contributes to the fight against infections by identifying and characterizing pathogens to assist in tracking, controlling, and preventing outbreaks. Our innovation offers a solution to control the spread of infections and save the power of antibiotics, thereby improving world health and saving costs for healthcare systems. bioinformatics, software, antibiotic resistance, infection diagnostics, microbiology, MRSA, next generation sequencing, whole genome sequencing, outbreak surveillance, software-as-a-service, clinical bacteriology, molecular biology, and genomics Type: | 3 | 14 |
 | Sigrid Therapeutics 100% Natural Stability For Your Blood Sugar Levels and Weight With science-backed, 100% natural solutions, we empower journeys toward balanced and healthier lives by optimizing metabolism and making well-being achievable every day. prediabetes, diabetes, blood sugar management, healthtech, obesity, innovation, medical device, biotech, and life science Type: | 2 | 21 |
 | Carbiotix Pioneering onsite upcycling of plant-based side-streams Carbiotix is an award-winning biotechnology company pioneering the onsite upcycling of plant-based side-streams. Carbiotix mission is to improve the health of people by increasing the consumption of prebiotics and other active ingredients from upcycled side-streams. Carbiotix offers one core service today called NutraCycle, an on-site upcycling and fortification service allowing food & beverage, ingredient, and feed producers to turn plant-based products into healthier, more profitable, and sustainable products. Gut Health, Microbiome, Prebiotics, Upcycling, Plant-based, Food & Beverage, Ingredient, Feed, Biotechnology, Process Engineering, Product Design, Active Ingredients, and Onsite Type: | 0 | 17 |
 | Samsara Therapeutics Treating Neurodegenerative Disease by Restoring Autophagy At Samsara Therapeutics, we’re on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases. Our innovative approach aims to delay the progression of several debilitating conditions, offering new possibilities for patients and their families. biotechnology, biopharmaceuticals, rare disease, neurodegeneration, longevity, drug discovery, and drug development Type: | 1 | 18 |
 | SENISCA Applying world-leading molecular genetics to solve the diseases and aesthetic signs of ageing SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics). Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence. This innovation works by restoring the ability of cells to ‘fine tune’ the expression of their genes to rejuvenate aged cells. At SENISCA, we are using this knowledge, concerning how and why cells become senescent, to develop a new … Type: | 1 | 21 |
 | Life Length Measuring life for the world Founded in 2010, Life Length stands out as a global leader in diagnostic biotechnology, specializing in telomere diagnostics. Our proprietary platform technology, TAT®, is based on the measurement of telomere variables and assays related to aging and age-related diseases. This patented technique allows quantification of telomere length at the individual cell level and is applicable to blood, cell culture and tissue samples. Recently, we have developed a biomarker for the early detection of prostate cancer with this technology. This biomarker is authorized by the AEMPS in Europe and by the CMS in the United States, … Type: | 2 | 48 |
 | enginzyme Developing technologies to meet the sustainability goals of the future Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the … Type: | 8 | 44 |
 | Uncommon We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Powered by breakthrough technology, our vision of a mouth-watering, affordable and healthy protein is fast approaching - we’ve pioneered a strategy to scale cultivated meat that eliminates the industry’s largest cost driver with zero genetic engineering. Previously known as Higher Steaks Ltd, we’ve successfully scaled from a compact start-up to a dynamic company of 50+ creative scientists, engineers and operators, committed to a massive takeover of the food industry. We’ve developed a scalable production process that can cut costs, drastically reduce waste materials and improve the … Type: | 9 | 58 |
 | Baseimmune A data-driven platform specialised in pathogen analysis for antigen discovery and vaccine design Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field. Vaccines Type: | 3 | 22 |
 | Equinom Ltd MannaTM AI Saas platform puts traders, millers, and ingredient processors in charge Determine the precise quality of your grains and predict how they will function when milled and used in food products and ingredients. Use Manna to improve your purchasing power, storage efficiency, and processing output, to save up to 10% of your respective costs. The MannaTM technology is the driving force behind our breakthroughs. This software enables us to zero in on top-quality grains by crossing insights from biochemical and field data with ingredient quality and functionality. After all, every grain’s biochemistry reveals the story of how that ingredient … Type: | 4 | 25 |
 | ATP Nutrition Ltd. Restoring the Balance At ATP, we believe a proactive, science-based approach to restore the balance between plant and soil health is the single most effective way to deliver the genetic potential of the crop. We challenge the status quo by utilizing agtech to monitor and drive productivity. ATP is a leading supplier of essential plant nutrients helping growers across North America realize the genetic potential of their crop. Founded in 2010, the company simplified the complicated area of plant nutrition by developing the System of Chemtrition, an agronomically sound management plan built upon the R3 Agronomic Platform. In 2018, ATP … Type: | 0 | 33 |
 | Salvia BioElectronics Giving people with migraine a better life | Medical device company pioneering migraine therapy | Located in NL & AUS Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empower people with migraine to reclaim their lives. Our personalized migraine therapy is tailored to the needs of individual patients. And our ambition doesn’t stop there. With our unique bioelectronic technology, we are also exploring applications for other neurological disorders. Our unwavering commitment is driven by a deep desire to restore hope, health and … Type: | 3 | 49 |
 | Newbury Pharmaceuticals AB Your local champion and alternative partner Newbury Pharmaceuticals was founded in 2020 by Swedish Karl Karlsson. We are rapidly growing and offer a product portfolio of specialty pharma medicines with focus on the Scandinavian markets. The portfolio strategy includes niche and value-added small molecules, products based on peptide technology as well as biosimilars in a variety of therapeutic categories. The portfolio consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology representing more than 70 percent. The company was listed on Nasdaq First North, February 2022. Type: | 0 | 10 |
 | Faron A CLEVER Approach to Fight Cancer. Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. Its lead program is bexmarilimab, its investigative precision immunotherapy in Phase I/II development as a novel macrophage checkpoint immunotherapy for patients with hematological malignancies. Bexmarilimab is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Faron is based in Turku, Finland and Boston, Massachusetts. Faron is listed on AIM under the ticker ‘FARN’ and Nasdaq First North Growth Market ("Nasdaq First North") under ticker FARON. Drug discovery, Drug development, Pharmaceuticals, Novel treatments … Type: | 1 | 42 |
 | CombiGene CombiGene’s business concept is to develop effective gene therapies for treatment of difficult-to-treat diseases for which adequate treatment methods are currently lacking. The company intends to take its candidate drugs through the phases of preclinical development and initial clinical studies under its own management, and subsequently continue development and commercialization under its own management or in collaboration with other partners. Founded on the basis of scientific discoveries made at Lund University and the University of Copenhagen, CombiGene has offices at Medicon Village in Lund, Sweden. The company is public and listed on the Swedish marketplace Nasdaq First North and the … Type: | 0 | 13 |
 | Patriapharma Complex APIs made in Hungary. Patriapharma is the international commercial partner of CF Pharma, Hungary, and draws on the pharmaceutical API development and manufacturing capabilities and extensive experience of its partner, whose R&D team maintains a highly specialized development pipeline. Pharmaceuticals and API-development | 0 | 20 |
 | IMIDomics Inc. Discovering and developing the next generation of medicines for immune-mediated inflammatory diseases (IMIDs) IMIDomics is a biotechnology company focused on Patient-Centric drug discovery for immune-mediated inflammatory diseases (IMIDs). Our goal is to discover new and impactful IMID drugs by focusing on carefully selected patients, and stratifying populations to identify those most likely to respond. IMIDomics is powered by a unique Clinical Discovery EngineTM, which integrates and analyzes proprietary clinical, epidemiological and patient-derived biomolecular datasets, generated in partnership with the Vall d’Hebron Institute of Research, to establish a deeper understanding of IMID diseases. By doing so, IMIDomics has identified previously unrecognized … Type: | 2 | 26 |
 | GlyProVac Exploring novel bacterial glycopeptide antigens to address unmet needs in vaccine development GlyProVac has via its proprietary platform technology, BEMAP, discovered that 1) O-linked protein glycosylation is a surprisingly abundant post translational modification in bacterial, 2) glycoproteins are linked to increased immunogenicity. GlyProVac aim to be the first to explore and exploit this novel class of antigens as candidates for vaccine development. The GlyProVac lead YghJ/SslE/AcfD is a conserved protein with a known biological function and has vaccine potential not only in ETEC but also in UPEC. Using BEMAP, GlyProVac has identified 59 glycosylated residues in YghJ. We are in … Type: | 0 | 11 |
 | HAWK Biosystems Quantifying Function in Spatial Proteomics. HAWK Biosystems are a biotechnology company founded by scientists from the Francis Crick Institute in London. HAWK sets a new spatial proteomics for precise quantitative analysis of protein functions in tissue. With an extraordinary dynamic range, HAWK’s QF-Pro® technology stands as the only solution capable of providing reliable, reproducible, and unbiased quantitative cut-off values related to protein functional states in tissues. Cancer, Immune-Oncology, Bio-imaging, Biomarker Analysis, Biomarker Discovery, and Research Type: | 5 | 22 |
 | SökerData AI-enabled platform providing access to correlated genomic and clinical datasets from under-represented groups AI-powered platform that accelerates access to correlated genomic and clinical datasets from under-represented groups (women and Black and ethnic minorities) in breast cancer and cardiovascular diseases. Type: | 2 | 4 |
 | KLISBio Silk innovation for life sciences KLISBio is a clinical-stage regenerative medicine company. We are developing several innovative technology platforms based entirely on natural silk fibroin, which allow for the creation of various solutions for endogenous tissue repair and regeneration. Silk is one of the most renowned and ancient materials used in medicine. In its raw state, silk consists of two main proteins, sericin and fibroin, with a glue-like layer of sericin coating two singular filaments of fibroin. Silk fibroin is fully biocompatible and promotes cell proliferation by also stimulating in-vivo tissue regeneration. Depending on the technology used, it provides a … Type: | 0 | 14 |
 | EnteroBiotix Mastering the microbiome, transforming lives® EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome. Type: | 2 | 59 |
 | Aerospec Holistic air pollution analysis to save lives by empowering individuals and governments to create a cleaner globe AeroSpec’s technology measures the chemical composition of air pollution - providing detailed analysis on its source, its makeup, and potential health effects. We provide comprehensive and actionable data that empowers research labs and environmental agencies to improve air quality and global health. High levels of particulate matter (PM) is associated with 7 million premature deaths worldwide and additional health effects. 84% of the global population is currently exposed to levels higher than recommended limits. Controlling air pollution requires informative monitoring, but understanding the … Type: | 3 | 10 |
 | Aelius Biotech Your gastrointestinal research partner. Aelius biotech specialise in the development of models of the mucosal surfaces of the human body. We currently have the capability to model the gastrointestinal tract and the airways, and are in the process of developing model systems to simulate the mucosal surfaces of the eye and cervico-vaginal tract. Type: | 0 | 12 |
 | Concr Solving data to enable precision therapy for all Concr is a techbio company providing predictive modelling solutions to enhance confidence and foresight about therapeutic efficacy of existing and emerging cancer drugs. By accurately predicting response for individual patients and cohorts, we enable more efficacious and informative trials, thereby improving probability of success of novel cancer therapeutics. Our Farr-Sight® platform, built on decades of astrophysics research, models diverse data interactions to simulate human disease biology, enabling accurate predictions with minimal data. This is especially valuable in early-stage trials and rare cancers. Validated through collaborations with Roche, Step Pharma, The Institute of … Type: | 5 | 12 |
 | Ceroflo Advancing the Treatment of Intracranial Atherosclerotic Disease (ICAD) A new evolution in the treatment of Intracranial Atherosclerotic Disease (ICAD). | 0 | 11 |
 | Sable Bio Empowering Discovery: Precision Insights for Safer Drug Targets. Prevent target safety failures with unique data insights and cutting-edge approaches. Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our advanced workflows assess clinical side effects and predict potential risks for drugs in development using a suite of data modalities. Empower your drug development process with our state-of-the-art solutions. Build trust with industry-leading validation across several proof points. Gain deeper insights into target safety, minimize risks, and optimize assay validation strategies. Type: | 0 | 9 |
 | Autolus Therapeutics Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases. Type: | 0 | 674 |
 | PulmoBioMed Ltd. Your Breath, Your Health PulmoBioMed commercialises state-of-the-art exhaled breath condensate & aerosol sampling technology as part of a platform for disease and environmental diagnostics. Our lead product, PBM-HALE is a passive fluid aerosol sampler engineered to segregate exhaled and environmental particles by size. Our technology solves key pains in avoiding sample contamination, preventing sample loss and generating highly reproducible data with digital molecular precision. The first of a series of products, PBM-HALE has demonstrated utility in biological agent capture, genomic/microbiomic analytics, and metabolomic profiling, through a one-stop solution. Our vision is to develop the first hand-held biomolecular analyser for medical, … Type: | 1 | 9 |
 | Desentum Oy Imagine a world without allergies Desentum is a clinical-stage, research-oriented biopharmaceutical company specialized in developing novel types of allergy immunotherapy products (aka allergy vaccines) that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. We have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, we have made discoveries that allow for improved design of vaccines against common types of allergies. Our goal is to provide long-term relief from allergic symptoms with only a few months of treatment, as well as reduce the social and economic burden allergies … Type: | 0 | 9 |
 | Octavian Therapeutics Octavian develops non-addictive small-molecule medicines targeting the ECS to revolutionise precision pain management. Octavian is at the frontier of precision pain management, developing innovative, non-addictive, small-molecule medicines that target the endocannabinoid system (ECS) to address the global challenge of chronic pain, which affects over 1.5 billion 1 people and drives dangerous dependence on opioids. Type: | 7 | 10 |
 | PepGen Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies. Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders. Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics Type: | 1 | 91 |
 | Orbis Medicines We are developing the future of drug discovery with a platform to discover, develop, and deliver drug candidates for challenging targets. Type: | 1 | 25 |
 | AMPLY Discovery Novel Biologics. Designed by Evolution. Discovered by AI. Novel Biologics. Designed by Evolution. Discovered by AI. AMPLY Discovery uses machine learning and synthetic biology to mine vast biological data to discover novel biologic drug and nutraceutical candidates. Using a proprietary in silico and in vitro hybrid platform to discover best-in-class molecules AMPLY is helping tackle some of humankind's greatest challenges such as cancer, MDR infections and metabolic diseases. Based in Belfast, Northern Ireland. Spin out from Queen's University Belfast. Biotechnology, Anti-infectives, Drug Discovery, AI, Machine Learning, Animal Health, Healthcare, Genomics, Metagenomics, Cancer, Biologics, Metabolic Diseases, Natural Drugs, Nutraceuticals, and Bioinformatics Type: | 2 | 7 |
 | Curve Therapeutics Revolutionary intracellular screening platform enables a new generation of first-in-class drugs. Our mission is to transform the discovery of first-in-class small molecule therapeutics by broadening the landscape of disease targets that can be drugged. Our Microcycle® platform enables direct screening for biologically active hits inside mammalian cells and creates a toolkit for hit-to-lead programmes. We are deploying our innovative platform to build a pipeline of first-in-class small molecules to address high priority, therapeutically relevant cancer targets. Type: | 3 | 34 |
 | Woodoo Augmented wood / Decarbonized materials for a new industrial revolution. Woodoo is unlocking the future of construction—leading the way toward more sustainable, resilient cities. How? By transforming underutilized hardwood into a cutting-edge wood composite material: STACK. STACK redefines what wood can do, providing a low-carbon and high-performance alternative to steel, aluminum and concrete for cladding and structural building applications. Tags: FrenchTech2030 Type: | 71 | 56 |
 | DEXSTR Insight Engine for Life Sciences DEXSTR is an innovative software company founded by bioinformatics experts experienced working in major pharmaceutical groups. In the course of their careers, the team realized just how much time laboratories spent trying to manage their unstructured data, and so they decided to come up with a solution: an Insight Engine for Life Sciences. With Inquiro, DEXSTR uses Artificial Intelligence combined with scientific public ontologies, to transform unmanageable data into structured and actionable information. Inquiro captures your scientific data, from any source, in any format, automatically associating metadata to your files and offers an intelligent search … Type: | 3 | 2 |
 | Vivet Therapeutics Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression. Gene Therapy Type: | 4 | 22 |
 | Data&Data - The intelligence of luxury Empowering brands with AI to curb the online grey market, capture resale trends, and attain competitive intelligence Founded in 2012, Data&Data is specialised in the luxury sector from watches and leather goods to fragrances. We help key decision makers to understand the ever-changing dynamics of the global online market. This enables them to make more informed and effective strategies. Data&Data is a privately held company, headquartered in Paris, France. Take a look at our blog on medium.com/@DATAANDDATA Big data, Analytics, Consulting, Data Management, Innovation, Information Management, Data science, Statistics, Datamining, Predictive analysis, Ecommerce Counterfeit Detection, Business intelligence, Artificial intelligence, Luxury, … Type: | 11 | 9 |
 | GlioCure A preclinical-stage drug-development company specialized in neuro-oncology GlioCure, a spin-off company of Angers and McGill Montreal universities, aims to treat glioblastoma that causes 200,000 deaths worldwide each year. To overcome this challenge, GlioCure is hyper-specialized and develops glioblastoma-specific drugs. GlioCure is currently focusing on the development of GC01, an anti-glioblastoma peptide discovered by Joël Eyer, Director of Research from INSERM, and covered by two patent families for which GlioCure owns worldwide exclusive rights. GlioCure's team has the experience and the know-how to ensure the successful completion of GC01’s development plan: Louis-Marie is a biotech entrepreneur with 15 years of experience … Type: | 12 | 5 |
 | iligo Agence d'études et de conseils en marketing iligo is an award-winning research agency and consultancy focused on understanding new consumer behaviors and assessing the effectiveness of marketing activities for brand building. iligo clients include multi-national advertisers, media companies and advertising agencies. We leverage cutting-edge technologies and innovative techniques in data collection and analyses. Check out our work at www.iligo.fr. Specialties marketing communications research, passive advertising effectiveness measurement, cross-platform advertising assessment, mobile research, digital out-of-home research, neuroscience, econometrics marketing, communication, etudes, consommateurs, mesure passive de l'efficacité publicitaire, exposition publicitaire cross-plateforme, études digital out of home, neuroscience, économétrie, études mobiles, émotions, études … Type: | 5 | 12 |
 | FLUOPTICS Part of Getinge Fluoptics is a young and innovative company in the field of fluorescence imaging for both clinical and preclinical applications. In clinics, Fluoptics develops solutions to optically guide cancer surgery. This approach is based on an intra-operative near infra-red fluorescence detector and fluorescent probes which specifically target tumors. This technology, extensively tested on animals, drastically improves cancer surgery in providing surgeons with an acute delineation of cancerous nodules during the surgery. Fluoptics develops and markets the Fluobeam, a unique fluorescence imaging system with an open design and an excellent sensitivity in the near infra-red spectrum. The company also proposes near infra-red … | 5 | 28 |
 | Cherry Biotech Alternative to Animal Testing for Drug Development Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing. Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates. By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert … Type: | 8 | 25 |
 | nextProtein Feeding the future. The world’s population is estimated to reach more than nine billion by 2050. Global food production will have to increase by 70 per cent to feed everyone. Meanwhile one third of all food produced is wasted. At nextProtein we’re driven by a personal desire to address land and resource scarcity and feed a rising population sustainably. nextProtein can produce the equivalent amount of protein from 100sqm as 100ha of soya field. Founded by couple Syrine Chaalala and Mohamed Gastli, we produce insect-based protein for animal feedstocks with a negligible carbon footprint, at a lower cost and with … Type: | 17 | 49 |
 | Pixium Vision S.A. Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons ! One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission … Type: | 10 | 15 |
 | FERMENTALG Natural Algae Solutions About Fermentalg: Based in Libourne (France), Fermental is an Industrial Biotechnology Company, Specialized in the Production of Oil Rich in Fatty Acids (Omega-3), Proteins and Natural Pigments (Phycocyanin) by fermentation of microalgae. Fermentalg Offer Innovative Products in the Global Market Such Food, Feed and Environment. FERMENTEG SHARES ARE LISTED ON EURONEXT IN PARIS (FR0011271600 - FALG). For more information, www.fermentag.com About Fermentalg: Based in Libourne (France), Fermentalg is an industrial biotechnology company, specialized in the production of oils rich in fatty acids (omega-3), proteins and natural pigments (phycocyanin) by fermentation of microalgae. Fermentalg offers innovative products for … Type: | 18 | 88 |
 | Bioxis Pharmaceuticals #BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid Type: | 5 | 25 |
 | Eligo Bioscience Precision medicines for the microbiome Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing. | 21 | 46 |
 | AlterDiag An innovative biotech company set to revolutionize the rapid diagnostics market. ALTERDIAG was founded in 2024 with a mission to develop and market innovative lateral-flow immunochromatographic tests to provide healthcare professionals who interact with patients with efficient, easy-to-use, and economically accessible diagnostic tools. These tools are designed to enable epidemiological screening of infectious diseases, aiming to combat or prevent new epidemics or pandemics. AlterDiag aspires to be internationally recognized as an innovative company and a scientific leader in the field of rapid diagnostic tests. R&D is thus central to its activities, and the company is building partnerships with prominent players … | 1 | 2 |
 | BiOWiSH Technologies Power your biology. Produce more with BiOWiSH® As much as 99% of bacteria in the natural world can’t be seen with the human eye and are unknown. Uncovering the secrets of microbes & biodiversity should be the scientific quest for our era. BiOWiSH® provides industry-leading biotechnology solutions for the agriculture and environmental management industries. Our product range is proven to deliver consistent performance globally for agricultural applications, aquaculture production, and the water treatment industry. Led by former P&G scientists and senior executives based in Cincinnati, Ohio, the company has formed partnerships with leading research institutions around the world, to explore … Type: | 0 | 55 |
 | Stem Genomics Next generation quality control for cell therapy Stem Genomics provides dedicated services to assess the genetic integrity of human stem cells. We help research scientists with specific assays and recommended workflows for the cell type they work with. Our flagship testing solution, iCS-digitalTM PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. It is particularly interesting for regularly monitoring stem cell lines in culture as well as for screening large numbers of clones, e.g., CRISPR-edited clones or human iPSC clones after reprogramming. We can also perform the following tests for you: G-Banding … Type: | 2 | 13 |
 | Humans Matter International Cognitive Design Company #Paris #Lyon #Grenoble #Toulouse #hongkong #Newyork #philadelphie Humans Matter is a cognitive design company whose mission is to support the transition of behavior in labor, health, education and society environments. Because the world suffers from its inability to act, Humans Matter innovates and designs solutions that act on the ability to act and whose effectiveness is scientifically measured. Humans Matter acts on the ability to act of individuals and collectives for: - Successful business transformations - increase the therapeutic efficiency of a care pathway - Acquire the skills necessary for new learning methods - Contribute to … Type: | 34 | 174 |
 | D4H - Data for Health Data for Health We reduce the uncertainty of health professionals and their patients based on the evidence the data provide. Machine Learning, Data Science, Bioinformatics, and DeepLearning Type: | 10 | 0 |
 | Biodexa Pharmaceuticals PLC Advancing Medicines for a Brighter Future Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain. The Company’s lead candidate, MTX110, is being studied in aggressive rare/orphan brain cancer indications including recurrent glioblastoma and diffuse midline glioma. MTX110 is a solubilised formulation of the histone deacetylase (HDAC) inhibitor, panobinostat. This proprietary formulation enables delivery of the product via convection-enhanced delivery (CED) at potentially chemotherapeutic doses directly to the site of the tumour, by-passing the blood-brain barrier and avoiding systemic toxicity. | 0 | 23 |
 | GENESIS Biomed Helping health & biotech companies, researchers and entrepreneurs making their projects and dreams come true. GENESIS Biomed is a consultancy firm in the biomedical healthcare sector specialized in providing consulting services in the genesis and first phases of lifecycle of biomedical spin-off and start-up companies, entrepreneurs and research centers. Based in our expertise we help entrepreneurs and researchers to shape their business plan and we support them in the private fundraising process. We have raised 68,5 M€ in the last years in 20 rounds. We are Associate Partner at EIT Health and we are engaged to 23 EU projects with … Type: | 10 | 18 |
 | Hemerion Therapeutics A new player committed to tackle #glioblastoma and #brain #cancer Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma. Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma. Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer. Type: | 41 | 16 |
 | Protonify Corporation Maximize purity, potency, and compliance in cannabis production with Protonify's advanced refining solutions. Protonify utilizes unique cannabis refining technology to ensure high purity, compliance, and scalability for regulated manufacturers. Upgrade your production with our advanced material and solutions. THC Formulation, THC Packaging, Medical Cannabis, Isolation and Extraction, Licensing, Intellectual Property, Global Sales and Marketing, THC Isolation, THCa API, THC API, THCa Isolation, Crystalization, and High Purity Intermediaries Type: | 0 | 9 |
 | Karyosoft Inc. In-House No-Code Genomics Platform helping Geneticists for Enhanced Research Efficiency and Accelerated Innovations We offer time and cost saving in-house, secure no-code genomics data management, analytics and visualization platform for molecular geneticists, bioinformaticians for enhanced research efficiency and accelerated innovations in agrigenomics and life sciences organizations. We offer no-code genomics software solutions for common challenges routinely that geneticists and bioinformaticians face in their NGS workflow specifically in secondary and tertiary analyses. Our platforms have been proven to create values for the life scientists and their organizations by saving time and cost, accelerating time to market and by providing higher data … Type: | 2 | 6 |
SMB